KEAP1 and early-onset autosomal dominant Alzheimer disease: A study in the cellular model of Alzheimer’s disease showed that sulforaphane increased Nrf2 expression by decreasing Nrf2 promoter demethylation, so its role on Keap1 promoter is also a possibility [56].